Eye Problems

 

Some chemotherapy drugs may cause eye problems, ranging from minor dry eyes to an increased risk of cataracts, which may lead to progressive loss of vision. Symptoms of eye problems should not be ignored; notify your doctor immediately if you have cloudy vision, blurred vision, sensitivity to light, severe eye pain, a persistent increase in tearing, or a sudden loss of vision.

What eye problems might be associated with cancer treatment?

Some cancer treatments may cause problems with your eyes, such as conjunctivitis, cataracts, dry eyes, photophobia, and watery eyes.

Conjunctivitis - This condition, also known as “pink eye,” is caused by a viral or bacterial infection, or an allergic reaction. Chemotherapy drugs tend to suppress your immune system, making you more susceptible to infection. These drugs can also kill the rapidly multiplying cells of the conjuntiva causing redness and tearing.

Cataracts - Cataracts are a cloudy area in the lens of your eye that prevents light from passing through. They are painless, but do lead to a progressive loss of vision. Cataracts usually occur in one eye and won’t spread to the other.

Dry eyes - Your eyes will feel dry if you are not producing enough tears, or if your tears are lacking an important chemical involved in lubricating your eyes.

Photophobia - Sensitivity to light is called photophobia. This condition causes pain in your eyes when you move from a dark space to a light one, such as going outside during the daytime.

Watery eyes - Some drugs cause you to produce too many tears, leading to watery eyes.

Which treatments cause eye problems?

Chemotherapy drugs that may cause eye problems are listed in the following table.

Eye Problems

Drugs

Conjunctivitis

Xeloda® (capecitabine)

BiCNU® (carmustine)

 Ellence® (epirubicin)

methotrexate

Neumega® (oprelvekin)

fluorouracil

Cataracts

Targretin® (bexarotene)

dexamethasone

hydrocortisone

methylprednisone

prednisone

tamoxifen

Dry eyes

(Vesanoid®) isotretinoin

 (Accutane®) tretinoin

Photophobia

 Ara-C® (cytarabine)

fluorouracil

isotretinoin

tretinoin

Watery eyes

Xeloda® (capecitabine)

cytarabine

 (Adriamycin®) doxorubicin

fluorouracil

Taxotere® (docetaxel)

 

What are some symptoms of eye problems?

You should notify your doctor immediately if you experience any of the following symptoms:

  • Cloudy vision
  • Blurred vision
  • Sensitivity to light
  • Severe eye pain
  • Sudden loss of vision
  • Persistent and bothersome tearing, especially if you are receiving docetaxel.

What are the treatments for eye problems?

How your eye problems are treated depends on your diagnosis and how severe your condition is. Frequently if the symptoms are related to a drug, decreasing the dose or temporarily discontinuing it may help. Medicine for eye problems is often administered in eyedrops. If docetaxel-induced tearing occurs, your tear ducts can be permanently scarred and stents (tubes to bypass the scarring) may be needed. If you have symptoms of eye problems, notify your doctor immediately.

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Cancer News
Some Oregon cities say no to pot dispensaries for now

April 9, 2014 — PORTLAND, Oregon (Reuters) - Over 20 Oregon cities and counties are moving to temporarily ban medical marijuana dispensaries ahead of a May deadline, reflecting a divide between liberal Portland and more conservative rural areas wary about allowing medical weed.

Japan drugmaker Takeda to fight $6 bln damages imposed by U.S. jury

April 8, 2014 — SAN FRANCISCO/TOKYO (Reuters) - Takeda Pharmaceutical Co Ltd said it would contest $6 billion in punitive damages imposed by a U.S. federal jury in a case alleging Japan's largest drugmaker had concealed cancer risks associated with its Actos diabetes drug.

For teen girls, fruits and veggies linked to lower risk of breast condition

April 7, 2014 — NEW YORK (Reuters Health) - Teenage girls who eat more colorful fruits and vegetables are less likely to develop benign breast disease as young adults, according to a new study.

Select news items provided by Reuters Health